Skip to main content

Table 4 Objective Response (n = 24)

From: A phase II study of concurrent chemo-radiotherapy with weekly nedaplatin in advanced squamous cell carcinoma of the uterine cervix

 

n

CR (%)

PR (%)

SD (%)

PD (%)

All stages

24

23 (95.8)

1 (4.2)

0 (0)

0 (0)

Stage IIa2 - IIb

21

20 (95.2)

1 (4.8)

0 (0)

0 (0)

Stage IIIb

3

3 (3/3)

0 (0)

0 (0)

0 (0)

Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us